What exactly did Morgan Stanley change in its ED analyst rating on Feb 20, 2026?

Morgan Stanley maintained an **Underweight** rating on Consolidated Edison, Inc. (ED) on Feb 20, 2026 and raised its **price target to $102 from $96**. The firm left recommended exposure unchanged while modestly improving its valuation view.

How should investors interpret an Underweight with a higher price target in the ED analyst rating?

An Underweight with a higher target means the analyst sees better valuation but still prefers less ED exposure than the benchmark. Investors should consider position sizing, regulatory risk, and yield goals before adjusting holdings.

Does the Morgan Stanley note change the near-term outlook for Consolidated Edison stock performance?

The raised **$102 price target** suggests a slightly firmer near-term valuation, but the maintained Underweight limits the note’s bullish impact. Expect modest market reaction and reassess allocations against broader utility coverage.

Where can I read the original analyst note referenced in the ED analyst rating update?

The Morgan Stanley update was summarized on TheFly; see the report here [TheFly](https://thefly.com/permalinks/entry.php/id4297534/0261286394/ED-Consolidated-Edison-price-target-raised-by--at-Morgan-Stanley-heres-why). For broader market context, consult major market sites such as MarketWatch [site]

Analyst Ratings

Morgan Stanley Maintains Underweight for Consolidated Edison, Inc. (ED) Feb 20 2026

ByDanny Kontos February 23, 2026February 23, 2026

ED analyst rating: Morgan Stanley maintained an Underweight on Consolidated Edison, Inc. (ED) on Feb 20, 2026, while raising its price target to $102 from $96. The firm left its view on relative exposure unchanged even as the target moved higher, signaling a cautious stance on total return versus peers. Morgan Stanley’s note, published via TheFly, came with a reported 2.06% price move since the call, equal to $2.26. Investors should read the rating and the raised target together to understand the balance between near-term valuation adjustment and the firm’s underweight allocation.